Recent from talks
All channels
Be the first to start a discussion here.
Be the first to start a discussion here.
Be the first to start a discussion here.
Be the first to start a discussion here.
Welcome to the community hub built to collect knowledge and have discussions related to 2-APBT.
Nothing was collected or created yet.
2-APBT
View on Wikipediafrom Wikipedia
| Clinical data | |
|---|---|
| Drug class | Serotonin–norepinephrine–dopamine releasing agent |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C11H13NS |
| Molar mass | 191.29 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
2-APBT is a monoamine releasing agent (MRA) of the benzothiophene family.[1][2] It acts specifically as a fairly well-balanced serotonin–norepinephrine–dopamine releasing agent (SNDRA), with EC50 values of 8.9 nM for serotonin, 21.6 nM for norepinephrine, and 38.6 nM for dopamine in rat brain synaptosomes.[2] 2-APBT was first described in the scientific literature by 2020.[1][2]
See also
[edit]References
[edit]- ^ a b Brandt SD, Carlino L, Kavanagh PV, Westphal F, Dreiseitel W, Dowling G, Baumann MH, Sitte HH, Halberstadt AL (August 2020). "Syntheses and analytical characterizations of novel (2-aminopropyl)benzo[b]thiophene (APBT) based stimulants". Drug Test Anal. 12 (8): 1109–1125. doi:10.1002/dta.2813. PMC 8281332. PMID 32372465.
- ^ a b c Rudin D, McCorvy JD, Glatfelter GC, Luethi D, Szöllősi D, Ljubišić T, Kavanagh PV, Dowling G, Holy M, Jaentsch K, Walther D, Brandt SD, Stockner T, Baumann MH, Halberstadt AL, Sitte HH (March 2022). "(2-Aminopropyl)benzo[β]thiophenes (APBTs) are novel monoamine transporter ligands that lack stimulant effects but display psychedelic-like activity in mice". Neuropsychopharmacology. 47 (4): 914–923. doi:10.1038/s41386-021-01221-0. PMC 8882185. PMID 34750565.